Douglas Adam Rubinson, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pancreatic Neoplasms | 30 | 2024 | 5351 | 1.590 |
Why?
|
Carcinoma, Pancreatic Ductal | 17 | 2024 | 1724 | 1.310 |
Why?
|
Dihydrouracil Dehydrogenase (NADP) | 1 | 2024 | 17 | 0.940 |
Why?
|
Adenocarcinoma | 13 | 2024 | 6315 | 0.750 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2024 | 1728 | 0.580 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 12 | 2024 | 11712 | 0.510 |
Why?
|
Pyridines | 1 | 2024 | 2879 | 0.400 |
Why?
|
Fluorouracil | 4 | 2024 | 1631 | 0.390 |
Why?
|
Stomach Neoplasms | 4 | 2024 | 1423 | 0.360 |
Why?
|
Colorectal Neoplasms | 6 | 2024 | 6853 | 0.320 |
Why?
|
Tumor Microenvironment | 6 | 2024 | 3844 | 0.290 |
Why?
|
Esophageal Neoplasms | 3 | 2024 | 1648 | 0.290 |
Why?
|
Membrane Proteins | 2 | 2024 | 7850 | 0.290 |
Why?
|
Anus Neoplasms | 2 | 2024 | 329 | 0.270 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2013 | 1613 | 0.250 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2024 | 640 | 0.220 |
Why?
|
Hypoalbuminemia | 1 | 2023 | 87 | 0.200 |
Why?
|
Esophagogastric Junction | 2 | 2024 | 341 | 0.190 |
Why?
|
Appendiceal Neoplasms | 1 | 2023 | 155 | 0.190 |
Why?
|
Lentivirus | 2 | 2004 | 506 | 0.180 |
Why?
|
Disease-Free Survival | 6 | 2020 | 6828 | 0.180 |
Why?
|
GTP Phosphohydrolases | 1 | 2024 | 518 | 0.180 |
Why?
|
Cell Adhesion Molecules | 5 | 2007 | 1602 | 0.180 |
Why?
|
Palliative Care | 1 | 2015 | 3607 | 0.170 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2021 | 211 | 0.170 |
Why?
|
Interleukin-1beta | 1 | 2024 | 998 | 0.160 |
Why?
|
Neoplasm Metastasis | 4 | 2024 | 4902 | 0.150 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2013 | 5253 | 0.150 |
Why?
|
Neutropenia | 1 | 2023 | 884 | 0.150 |
Why?
|
Receptor, IGF Type 1 | 1 | 2020 | 380 | 0.150 |
Why?
|
RNA Interference | 2 | 2005 | 2846 | 0.150 |
Why?
|
Phosphoproteins | 5 | 2007 | 2440 | 0.150 |
Why?
|
Pseudopodia | 3 | 2007 | 168 | 0.150 |
Why?
|
Jews | 1 | 2019 | 364 | 0.140 |
Why?
|
Receptor, erbB-2 | 2 | 2024 | 2554 | 0.140 |
Why?
|
Peritoneal Neoplasms | 1 | 2023 | 707 | 0.140 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2016 | 52 | 0.130 |
Why?
|
Tricarboxylic Acids | 1 | 2016 | 26 | 0.130 |
Why?
|
Microfilament Proteins | 5 | 2007 | 1135 | 0.130 |
Why?
|
Neoplasm Proteins | 3 | 2018 | 3610 | 0.130 |
Why?
|
Iron Regulatory Protein 1 | 1 | 2016 | 37 | 0.130 |
Why?
|
Myeloid Cells | 1 | 2020 | 820 | 0.130 |
Why?
|
Cholangiocarcinoma | 1 | 2021 | 550 | 0.130 |
Why?
|
Neurites | 2 | 2007 | 390 | 0.130 |
Why?
|
Bile Duct Neoplasms | 1 | 2021 | 602 | 0.130 |
Why?
|
DNA Copy Number Variations | 1 | 2024 | 2013 | 0.120 |
Why?
|
Medical History Taking | 1 | 2019 | 773 | 0.120 |
Why?
|
Humans | 51 | 2024 | 760621 | 0.120 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2023 | 951 | 0.120 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2024 | 4024 | 0.120 |
Why?
|
Aged | 27 | 2024 | 169152 | 0.120 |
Why?
|
Mutation | 10 | 2024 | 29932 | 0.120 |
Why?
|
Cholecalciferol | 1 | 2019 | 550 | 0.110 |
Why?
|
Genomics | 3 | 2023 | 5794 | 0.110 |
Why?
|
Piperazines | 1 | 2024 | 2525 | 0.110 |
Why?
|
Diabetes Complications | 1 | 2020 | 1341 | 0.110 |
Why?
|
Leukocytes | 1 | 2021 | 2026 | 0.110 |
Why?
|
Cell Line, Tumor | 3 | 2024 | 16939 | 0.100 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 3334 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2020 | 9276 | 0.100 |
Why?
|
Drug Delivery Systems | 1 | 2024 | 2221 | 0.100 |
Why?
|
Male | 30 | 2024 | 359744 | 0.100 |
Why?
|
Genes, Retinoblastoma | 2 | 2002 | 125 | 0.100 |
Why?
|
Antineoplastic Agents | 3 | 2024 | 13630 | 0.100 |
Why?
|
Middle Aged | 25 | 2024 | 220352 | 0.100 |
Why?
|
Female | 31 | 2024 | 391270 | 0.100 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2014 | 264 | 0.100 |
Why?
|
Papillomavirus Infections | 1 | 2024 | 1607 | 0.100 |
Why?
|
Proportional Hazards Models | 8 | 2019 | 12531 | 0.100 |
Why?
|
Paclitaxel | 3 | 2024 | 1736 | 0.100 |
Why?
|
Pyrimidines | 1 | 2024 | 3016 | 0.100 |
Why?
|
Signal Transduction | 2 | 2020 | 23376 | 0.090 |
Why?
|
Lymph Node Excision | 1 | 2017 | 1303 | 0.090 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2015 | 861 | 0.090 |
Why?
|
Genomic Instability | 1 | 2015 | 704 | 0.090 |
Why?
|
Vitamins | 1 | 2019 | 1634 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 2 | 2023 | 4490 | 0.090 |
Why?
|
Pancreatectomy | 3 | 2020 | 810 | 0.090 |
Why?
|
Hydroxychloroquine | 1 | 2014 | 427 | 0.090 |
Why?
|
Deoxycytidine | 2 | 2024 | 873 | 0.080 |
Why?
|
Weight Loss | 1 | 2020 | 2686 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5643 | 0.080 |
Why?
|
Aged, 80 and over | 11 | 2021 | 58995 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2016 | 2919 | 0.070 |
Why?
|
Survival Analysis | 4 | 2021 | 10182 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2023 | 8515 | 0.070 |
Why?
|
Vitamin D | 2 | 2019 | 3291 | 0.070 |
Why?
|
Dietary Supplements | 1 | 2019 | 3392 | 0.070 |
Why?
|
Autophagy | 1 | 2014 | 1337 | 0.070 |
Why?
|
Lymph Nodes | 1 | 2017 | 3486 | 0.070 |
Why?
|
Pancreas | 2 | 2024 | 1677 | 0.060 |
Why?
|
Smoking | 3 | 2018 | 9073 | 0.060 |
Why?
|
Gene Expression Profiling | 2 | 2018 | 9411 | 0.060 |
Why?
|
RNA Precursors | 2 | 2003 | 212 | 0.060 |
Why?
|
Actins | 4 | 2007 | 2049 | 0.060 |
Why?
|
Therapeutics | 1 | 2005 | 114 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2018 | 3616 | 0.060 |
Why?
|
Physiology | 1 | 2005 | 112 | 0.060 |
Why?
|
CA-19-9 Antigen | 1 | 2024 | 106 | 0.060 |
Why?
|
Body Mass Index | 3 | 2020 | 12914 | 0.060 |
Why?
|
Cohort Studies | 7 | 2023 | 41335 | 0.060 |
Why?
|
Carcinoma | 1 | 2015 | 2331 | 0.060 |
Why?
|
Prospective Studies | 8 | 2024 | 54303 | 0.050 |
Why?
|
Luminescent Proteins | 2 | 2003 | 835 | 0.050 |
Why?
|
Edema | 2 | 2023 | 769 | 0.050 |
Why?
|
Cytokines | 1 | 2018 | 7343 | 0.050 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2002 | 84 | 0.050 |
Why?
|
Genetic Variation | 1 | 2018 | 6551 | 0.050 |
Why?
|
RNA | 2 | 2023 | 2722 | 0.050 |
Why?
|
Cerebral Cortex | 3 | 2007 | 5761 | 0.050 |
Why?
|
Nucleic Acid Conformation | 2 | 2003 | 899 | 0.050 |
Why?
|
Survival Rate | 4 | 2019 | 12808 | 0.050 |
Why?
|
Adult | 14 | 2024 | 219994 | 0.050 |
Why?
|
Claudins | 1 | 2023 | 115 | 0.050 |
Why?
|
Prognosis | 5 | 2023 | 29658 | 0.050 |
Why?
|
Mice | 11 | 2024 | 81208 | 0.050 |
Why?
|
Receptors, Interleukin-2 | 1 | 2003 | 562 | 0.050 |
Why?
|
ADP-Ribosylation Factors | 1 | 2002 | 133 | 0.050 |
Why?
|
Saccharomyces cerevisiae | 2 | 2003 | 2698 | 0.050 |
Why?
|
Ribonucleoproteins | 1 | 2003 | 372 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2024 | 65017 | 0.050 |
Why?
|
Proline | 1 | 2002 | 457 | 0.040 |
Why?
|
Embryo, Mammalian | 2 | 2007 | 1674 | 0.040 |
Why?
|
Green Fluorescent Proteins | 2 | 2003 | 2057 | 0.040 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2023 | 629 | 0.040 |
Why?
|
Albumins | 1 | 2023 | 575 | 0.040 |
Why?
|
Lymphatic Metastasis | 2 | 2019 | 2943 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 642 | 0.040 |
Why?
|
Ribonucleoproteins, Small Nuclear | 1 | 2000 | 75 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2024 | 4550 | 0.040 |
Why?
|
Diabetes Mellitus | 2 | 2018 | 5889 | 0.040 |
Why?
|
Germ-Line Mutation | 2 | 2018 | 1841 | 0.040 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2023 | 454 | 0.040 |
Why?
|
Animals | 13 | 2024 | 167963 | 0.040 |
Why?
|
Gene Amplification | 1 | 2024 | 1085 | 0.040 |
Why?
|
Base Sequence | 4 | 2003 | 12446 | 0.040 |
Why?
|
Infusions, Intravenous | 1 | 2024 | 2234 | 0.040 |
Why?
|
Cells, Cultured | 5 | 2007 | 18957 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2019 | 39261 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2022 | 10827 | 0.040 |
Why?
|
Camptothecin | 1 | 2022 | 590 | 0.040 |
Why?
|
Inflammation | 1 | 2018 | 10756 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12159 | 0.040 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2023 | 611 | 0.040 |
Why?
|
DNA, Neoplasm | 1 | 2023 | 1745 | 0.040 |
Why?
|
Rabbits | 1 | 2024 | 4773 | 0.040 |
Why?
|
Organoplatinum Compounds | 1 | 2019 | 410 | 0.040 |
Why?
|
Leucovorin | 1 | 2019 | 641 | 0.040 |
Why?
|
Molecular Targeted Therapy | 2 | 2021 | 2803 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2002 | 1343 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17790 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2022 | 965 | 0.030 |
Why?
|
Aconitic Acid | 1 | 2016 | 13 | 0.030 |
Why?
|
Cotinine | 1 | 2017 | 203 | 0.030 |
Why?
|
Molecular Sequence Data | 3 | 2004 | 17624 | 0.030 |
Why?
|
Isocitrates | 1 | 2016 | 23 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2023 | 1827 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 15789 | 0.030 |
Why?
|
Antibody Formation | 1 | 2021 | 1400 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 2 | 2014 | 1077 | 0.030 |
Why?
|
Fungal Proteins | 1 | 2000 | 911 | 0.030 |
Why?
|
Incidence | 3 | 2020 | 21392 | 0.030 |
Why?
|
Risk Factors | 6 | 2019 | 74359 | 0.030 |
Why?
|
Endothelial Cells | 1 | 2007 | 3539 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2019 | 12427 | 0.030 |
Why?
|
Cell Movement | 2 | 2007 | 5206 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 6544 | 0.030 |
Why?
|
Mice, Knockout | 4 | 2014 | 14372 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2418 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1091 | 0.030 |
Why?
|
Pituitary Neoplasms | 1 | 2002 | 1313 | 0.030 |
Why?
|
Carrier Proteins | 2 | 2004 | 4938 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2023 | 22023 | 0.030 |
Why?
|
Pancreaticoduodenectomy | 1 | 2017 | 508 | 0.030 |
Why?
|
United States | 6 | 2018 | 72461 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2014 | 372 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2053 | 0.030 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2018 | 607 | 0.030 |
Why?
|
Neoplasms | 1 | 2022 | 22072 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2023 | 6538 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2003 | 3380 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2016 | 698 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 2018 | 11071 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2017 | 1007 | 0.030 |
Why?
|
Neoadjuvant Therapy | 1 | 2022 | 2821 | 0.020 |
Why?
|
RNA, Fungal | 2 | 2003 | 160 | 0.020 |
Why?
|
Obesity | 1 | 2013 | 12922 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1484 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2000 | 1894 | 0.020 |
Why?
|
Neurons | 2 | 2007 | 9426 | 0.020 |
Why?
|
Medical Oncology | 1 | 2023 | 2313 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2380 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2000 | 1854 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2003 | 9530 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2005 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2007 | 11481 | 0.020 |
Why?
|
Exons | 1 | 2016 | 2388 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7233 | 0.020 |
Why?
|
Stem Cells | 1 | 2003 | 3523 | 0.020 |
Why?
|
Papillomaviridae | 1 | 2016 | 1117 | 0.020 |
Why?
|
DNA Methylation | 1 | 2024 | 4373 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2024 | 80372 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1741 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 4107 | 0.020 |
Why?
|
Disease Progression | 2 | 2018 | 13502 | 0.020 |
Why?
|
Biomedical Research | 1 | 2005 | 3426 | 0.020 |
Why?
|
DNA Repair | 1 | 2018 | 2039 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3361 | 0.020 |
Why?
|
NADPH Dehydrogenase | 1 | 2007 | 44 | 0.020 |
Why?
|
Phenotype | 2 | 2023 | 16546 | 0.020 |
Why?
|
Myosin Type II | 1 | 2007 | 70 | 0.020 |
Why?
|
Age of Onset | 1 | 2014 | 3301 | 0.020 |
Why?
|
Intercellular Junctions | 1 | 2007 | 197 | 0.020 |
Why?
|
Growth Cones | 1 | 2007 | 117 | 0.020 |
Why?
|
Actomyosin | 1 | 2007 | 109 | 0.020 |
Why?
|
Umbilical Veins | 1 | 2007 | 426 | 0.020 |
Why?
|
DNA Primers | 2 | 2002 | 2819 | 0.020 |
Why?
|
Chimera | 1 | 2007 | 453 | 0.020 |
Why?
|
Protein Structure, Tertiary | 2 | 2004 | 3800 | 0.020 |
Why?
|
Laminin | 1 | 2007 | 405 | 0.020 |
Why?
|
Lymphocytes | 1 | 2014 | 2611 | 0.020 |
Why?
|
Women's Health | 1 | 2016 | 2056 | 0.020 |
Why?
|
Nurses | 1 | 2016 | 2467 | 0.020 |
Why?
|
Myosins | 1 | 2007 | 405 | 0.020 |
Why?
|
Apoptosis | 1 | 2002 | 9501 | 0.020 |
Why?
|
Nervous System Malformations | 1 | 2007 | 244 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4642 | 0.020 |
Why?
|
Chromosome Mapping | 2 | 2003 | 4625 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 2 | 2004 | 3735 | 0.020 |
Why?
|
Binding Sites | 2 | 2004 | 6048 | 0.010 |
Why?
|
RNA, Transfer, Arg | 1 | 2003 | 2 | 0.010 |
Why?
|
Vaccinia | 1 | 2004 | 71 | 0.010 |
Why?
|
Focal Adhesions | 1 | 2004 | 114 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11152 | 0.010 |
Why?
|
Chromosomes, Fungal | 1 | 2003 | 111 | 0.010 |
Why?
|
Odds Ratio | 1 | 2016 | 9716 | 0.010 |
Why?
|
Body Patterning | 1 | 2007 | 632 | 0.010 |
Why?
|
Fibroblasts | 2 | 2004 | 4090 | 0.010 |
Why?
|
Cytoskeleton | 1 | 2007 | 1167 | 0.010 |
Why?
|
Vinculin | 1 | 2002 | 59 | 0.010 |
Why?
|
Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2002 | 86 | 0.010 |
Why?
|
Glutathione Transferase | 1 | 2004 | 565 | 0.010 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2004 | 617 | 0.010 |
Why?
|
Blood Vessels | 1 | 2007 | 1112 | 0.010 |
Why?
|
Microtubules | 1 | 2007 | 1072 | 0.010 |
Why?
|
Threonine | 1 | 2002 | 272 | 0.010 |
Why?
|
Genetic Complementation Test | 1 | 2002 | 555 | 0.010 |
Why?
|
Indicators and Reagents | 1 | 2002 | 461 | 0.010 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2002 | 295 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5791 | 0.010 |
Why?
|
Genotype | 1 | 2016 | 12960 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2002 | 613 | 0.010 |
Why?
|
Ribonucleoprotein, U4-U6 Small Nuclear | 1 | 2000 | 14 | 0.010 |
Why?
|
Loss of Heterozygosity | 1 | 2002 | 659 | 0.010 |
Why?
|
Ribonucleoprotein, U1 Small Nuclear | 1 | 2000 | 37 | 0.010 |
Why?
|
Genes, p53 | 1 | 2002 | 713 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2004 | 2753 | 0.010 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2002 | 483 | 0.010 |
Why?
|
Comorbidity | 1 | 2014 | 10551 | 0.010 |
Why?
|
Aorta | 1 | 2007 | 2039 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2002 | 929 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2004 | 1697 | 0.010 |
Why?
|
Autoantigens | 1 | 2003 | 877 | 0.010 |
Why?
|
Spliceosomes | 1 | 2000 | 129 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 2002 | 1753 | 0.010 |
Why?
|
Genes, Fungal | 1 | 2000 | 439 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2007 | 6216 | 0.010 |
Why?
|
Serine | 1 | 2002 | 830 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2002 | 1529 | 0.010 |
Why?
|
HeLa Cells | 1 | 2004 | 3105 | 0.010 |
Why?
|
RNA Stability | 1 | 2000 | 333 | 0.010 |
Why?
|
Ligands | 1 | 2004 | 3276 | 0.010 |
Why?
|
Kinetics | 1 | 2004 | 6377 | 0.010 |
Why?
|
Neural Pathways | 1 | 2007 | 3040 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2014 | 22053 | 0.010 |
Why?
|
Transcription Factors | 1 | 2016 | 12103 | 0.010 |
Why?
|
Hemorrhage | 1 | 2007 | 3600 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2007 | 4433 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2004 | 3442 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18137 | 0.010 |
Why?
|
Cell Division | 1 | 2002 | 4463 | 0.010 |
Why?
|
Heart | 1 | 2007 | 4393 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 58741 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 87810 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 13451 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 40165 | 0.010 |
Why?
|
Risk Assessment | 1 | 2013 | 24123 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2019 | 21025 | 0.010 |
Why?
|
Phosphorylation | 1 | 2002 | 8313 | 0.010 |
Why?
|
Cell Line | 1 | 2004 | 15620 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2007 | 9585 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2002 | 4407 | 0.010 |
Why?
|
Protein Binding | 1 | 2000 | 9335 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 2004 | 11903 | 0.000 |
Why?
|
Rats | 1 | 2002 | 23711 | 0.000 |
Why?
|
Pregnancy | 1 | 2007 | 29749 | 0.000 |
Why?
|